CausalSentinel

Protein Dossier — CNDP1 (Beta-Ala-His dipeptidase)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Gallbladder cancer 2.82 0.874 0.00126 Wald ratio 1 cis NA
Birth weight -0.0263 0.0109 0.0155 Wald ratio 1 cis NA
Invasive mucinous ovarian cancer 0.275 0.123 0.0246 Wald ratio 1 cis NA
Non-cancer illness code self-reported: muscle or soft tissue injuries -0.239 0.108 0.0263 Wald ratio 1 cis NA
Urate 0.04 0.0186 0.0313 Wald ratio 1 cis NA
Diagnoses - main ICD10: S76 Injury of muscle and tendon at hip and thigh level 0.464 0.225 0.0391 Wald ratio 1 cis NA
HOMA-IR -0.0274 0.0134 0.0411 Wald ratio 1 cis NA
Pulse rate 0.0253 0.0125 0.0435 Wald ratio 1 cis NA
Glioma -0.26 0.129 0.0442 Wald ratio 1 cis NA
Lumbar spine bone mineral density -0.0486 0.025 0.0519 Wald ratio 1 cis NA
Diagnoses - main ICD10: K80 Cholelithiasis 0.0879 0.0453 0.0523 Wald ratio 1 cis NA
Diagnoses - main ICD10: K35 Acute appendicitis -0.25 0.134 0.0607 Wald ratio 1 cis NA
…and 91 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-3604_6_4 CNDP1 Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

40 association rows across 12 traits (39 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Circulating CNDP1 levels 4e-467 rs17817077 7 GCST90860496 no MR -> candidate analysis
CNDP1/EGFR protein level ratio 2e-275 rs17238585 1 GCST90314146 no MR -> candidate analysis
CNDP1 protein levels 1e-211 rs4329999 8 GCST90468796 no MR -> candidate analysis
Beta-Ala-His dipeptidase levels 4e-145 rs17817077 10 GCST90246651 no MR -> candidate analysis
Serum levels of protein CNDP1 2e-69 rs17817077 4 GCST90089039 no MR -> candidate analysis
Beta-Ala-His dipeptidase (analyte X7870.8) levels 7e-34 rs58692747 1 GCST90427120 no MR -> candidate analysis
Blood protein levels 1e-28 rs62099911 2 GCST006585 no MR -> candidate analysis
Cerebrospinal fluid homocarnosine levels 1e-19 rs56042934 3 GCST90318245 no MR -> candidate analysis
Cerebrospinal fluid protein CNDP1 levels 2e-17 rs4329999 1 GCST90944972 no MR -> candidate analysis
Beta-Ala-His dipeptidase (analyte X5456.59) levels 1e-15 rs58692747 1 GCST90426351 no MR -> candidate analysis
Urine carnosine levels in chronic kidney disease 1e-12 rs17089382 1 GCST90264901 no MR -> candidate analysis
Neovascular age-related macular degeneration 1e-5 rs9965945 1 GCST90860786 no MR -> candidate analysis

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 167 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
response to antihypertensive drug 0.421 common-variant locus no MR -> candidate analysis
multiple sclerosis 0.338 common-variant locus no MR -> candidate analysis
myopia 0.059 common-variant locus no MR -> candidate analysis
stroke disorder 0.058 common-variant locus no MR -> candidate analysis
alcohol drinking 0.058 common-variant locus no MR -> candidate analysis
Retinal hemorrhage 0.045 common-variant locus no MR -> candidate analysis
duodenal ulcer 0.035 common-variant locus no MR -> candidate analysis

Of the 7 rows above, 7 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability not available — no ChEMBL target (undrugged)
gnomAD constraint pLI=6.8e-12, LOEUF=0.974 — LoF-tolerant
GWAS Catalog 87 unique SNPs / 174 rows
ClinVar 276 records; 6 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance